Abbott Laboratories Statement of changes in Director/PDMR Shareholding (4826D)
07 Julho 2016 - 3:00AM
UK Regulatory
TIDMABT
RNS Number : 4826D
Abbott Laboratories
06 July 2016
Notification to RNS
Company: Abbott Laboratories
TIDM: ABT
Headline: Abbott Laboratories Files Forms 4
Abbott Laboratories (the "Company")
6 July 2016
Abbott Laboratories Files Forms 4
The Company informs its shareholders that on 6 July, 2016, in
accordance with Section 16(a) of the U.S. Securities Exchange Act
of 1934, as amended, several Forms 4 (the report on Form 4 being a
statement of changes in the beneficial ownership of its officers,
directors and 10% owners) ("Form 4") were filed with the U.S.
Securities and Exchange Commission ("SEC"). The Forms 4 can be
found on the SEC website at http://www.sec.gov.
A copy of the Forms 4 have been submitted to the National
Storage Mechanism on the date of this announcement and is, or will
shortly be, available for inspection at
http://www.morningstar.co.uk/uk/NSM.
Issued by: Abbott Laboratories
CONTACT: Financial: Scott Leinenweber, +1-224-668-0791, Michael
Comilla, +1-224-668-1872, or Jeffrey Byrne, +1-224-668-8808, or
Media: Scott Stoffel, +1-224-668-5201, Darcy Ross, +1-224-667-3655,
or Elissa Maurer, +1-224-668-3309.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAFXKEFXKEAF
(END) Dow Jones Newswires
July 07, 2016 02:00 ET (06:00 GMT)
Abbott Labs (LSE:ABT)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Abbott Labs (LSE:ABT)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024